LY3866288

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3866288, covering 2025-04-01 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3866288 in Healthy Participants [Phase 1]